Valeant has wasted no time in getting down to brass tacks at its newly acquired subsidiary Dendreon. The company notified the state of Washington that it is laying off 77 staffers from the biotech’s steadily shrinking roster of employees, according to a report from the Seattle Times.

…read more

Source: Valeant starts carving up what remains of Dendreon, axing 77 staffers


0 No comments